165 related articles for article (PubMed ID: 24927186)
1. Evaluation of the NovaSure endometrial ablation procedure in women with uterine cavity length over 10 cm.
Thiel JA; Briggs MM; Pohlman S; Rattray D
J Obstet Gynaecol Can; 2014 Jun; 36(6):491-497. PubMed ID: 24927186
[TBL] [Abstract][Full Text] [Related]
2. Radiofrequency endometrial ablation in patients with a history of low transverse cesarean delivery.
Adkins RT; Bressman PL; Bressman PB; Lucas TL
J Minim Invasive Gynecol; 2013; 20(6):848-52. PubMed ID: 24183276
[TBL] [Abstract][Full Text] [Related]
3. Effect of undiagnosed deep adenomyosis after failed NovaSure endometrial ablation.
Mengerink BB; van der Wurff AA; ter Haar JF; van Rooij IA; Pijnenborg JM
J Minim Invasive Gynecol; 2015 Feb; 22(2):239-44. PubMed ID: 25460320
[TBL] [Abstract][Full Text] [Related]
4. Intraoperative Predictors of Long-term Outcomes After Radiofrequency Endometrial Ablation.
Shazly SA; Famuyide AO; El-Nashar SA; Breitkopf DM; Hopkins MR; Laughlin-Tommaso SK
J Minim Invasive Gynecol; 2016; 23(4):582-9. PubMed ID: 26867699
[TBL] [Abstract][Full Text] [Related]
5. Post-Ablation Cavity Evaluation: A Prospective Multicenter Observational Clinical Study to Evaluate Hysteroscopic Access to the Uterine Cavity 4 Years after Water Vapor Endometrial Ablation for the Treatment of Heavy Menstrual Bleeding.
Johns DA; Garza-Leal JG; Diamond MP; Harris M
J Minim Invasive Gynecol; 2020; 27(6):1273-1280. PubMed ID: 31536836
[TBL] [Abstract][Full Text] [Related]
6. Nonresectoscopic endometrial ablation in high-risk surgical patients: a cohort study.
Ajao MO; El-Nashar SA; Khan Z; Hopkins MR; Creedon DJ; Famuyide AO
J Minim Invasive Gynecol; 2013; 20(4):487-91. PubMed ID: 23870238
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of endometrial ablation for treating abnormal uterine bleeding in pre- and postmenopausal women with liver cirrhosis.
Liu Q; Li XL; Liu JJ; Song XH; Jiang XY; Li W; Zhang H; Pan CQ
J Obstet Gynaecol Res; 2016 Dec; 42(12):1753-1760. PubMed ID: 27647778
[TBL] [Abstract][Full Text] [Related]
8. Office endometrial ablation with local anesthesia using the HydroThermAblator system: Comparison of outcomes in patients with submucous myomas with those with normal cavities in 246 cases performed over 5(1/2) years.
Glasser MH; Heinlein PK; Hung YY
J Minim Invasive Gynecol; 2009; 16(6):700-7. PubMed ID: 19896596
[TBL] [Abstract][Full Text] [Related]
9. A Prospective, Multicenter, Pivotal Trial to Evaluate the Safety and Effectiveness of the AEGEA Vapor Endometrial Ablation System.
Levie MD; Chudnoff SG
J Minim Invasive Gynecol; 2019; 26(4):679-687. PubMed ID: 30036631
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and patient satisfaction after NovaSure and Minerva endometrial ablation for treating abnormal uterine bleeding: a retrospective comparative study.
Scordalakes C; delRosario R; Shimer A; Stankiewicz R
Int J Womens Health; 2018; 10():137-145. PubMed ID: 29713204
[TBL] [Abstract][Full Text] [Related]
11. Preoperative uterine bleeding pattern and risk of endometrial ablation failure.
Smithling KR; Savella G; Raker CA; Matteson KA
Am J Obstet Gynecol; 2014 Nov; 211(5):556.e1-6. PubMed ID: 25019488
[TBL] [Abstract][Full Text] [Related]
12. Clinical analysis of 2152 cases of abnormal uterine bleeding treated by NovaSure endometrial ablation.
Xie H; Wan Y; Yi S; Zeng F; Sun X; Yang Y; Xiao S
Int J Gynaecol Obstet; 2022 Aug; 158(2):301-307. PubMed ID: 34653258
[TBL] [Abstract][Full Text] [Related]
13. Predictors of Long-Term NovaSure Endometrial Ablation Failure.
Lybol C; van der Coelen S; Hamelink A; Bartelink LR; Nieboer TE
J Minim Invasive Gynecol; 2018; 25(7):1255-1259. PubMed ID: 29550389
[TBL] [Abstract][Full Text] [Related]
14. Effect of Radiofrequency Endometrial Ablation on Dysmenorrhea.
Wyatt SN; Banahan T; Tang Y; Nadendla K; Szychowski JM; Jenkins TR
J Minim Invasive Gynecol; 2016; 23(7):1163-1166. PubMed ID: 27590567
[TBL] [Abstract][Full Text] [Related]
15. Hysteroscopic rollerball endometrial ablation as an alternative treatment for adenomyosis with menorrhagia and/or dysmenorrhea.
Preutthipan S; Herabutya Y
J Obstet Gynaecol Res; 2010 Oct; 36(5):1031-6. PubMed ID: 20846253
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of NovaSure
Philip CA; Le Mitouard M; Maillet L; de Saint-Hilaire P; Huissoud C; Cortet M; Dubernard G
Eur J Obstet Gynecol Reprod Biol; 2018 Aug; 227():46-51. PubMed ID: 29886317
[TBL] [Abstract][Full Text] [Related]
17. Use of the NovaSure Impedance Controlled Endometrial Ablation System in patients with intracavitary disease: 12-month follow-up results of a prospective, single-arm clinical study.
Sabbah R; Desaulniers G
J Minim Invasive Gynecol; 2006; 13(5):467-71. PubMed ID: 16962534
[TBL] [Abstract][Full Text] [Related]
18. A double-blind randomized trial comparing the Cavaterm and the NovaSure endometrial ablation systems for the treatment of dysfunctional uterine bleeding.
Abbott J; Hawe J; Hunter D; Garry R
Fertil Steril; 2003 Jul; 80(1):203-8. PubMed ID: 12849825
[TBL] [Abstract][Full Text] [Related]
19. NovaSure impedance controlled system for endometrial ablation: the experience of the first UK reference centre.
Elmardi A; Furara S; Khan F; Hamza M
J Obstet Gynaecol; 2009 Jul; 29(5):419-22. PubMed ID: 19603322
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of endometrial assessment after thermal ablation.
Ahonkallio SJ; Liakka AK; Martikainen HK; Santala MJ
Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):69-71. PubMed ID: 19615812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
